Evaluation of exacerbations and blood eosinophils in UK and US COPD populations

BACKGROUND: Blood eosinophil counts and history of exacerbations have been proposed as predictors of patients with chronic obstructive pulmonary disease (COPD) who may benefit from triple therapy (inhaled corticosteroid, long-acting β(2)-agonist and long-acting muscarinic antagonist). METHODS: In a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelmeier, Claus F., Kostikas, Konstantinos, Fang, Juanzhi, Tian, Hengfeng, Jones, Bethan, Morgan, Christopher Ll, Fogel, Robert, Gutzwiller, Florian S., Cao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686508/
https://www.ncbi.nlm.nih.gov/pubmed/31391053
http://dx.doi.org/10.1186/s12931-019-1130-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686508/
https://www.ncbi.nlm.nih.gov/pubmed/31391053
http://dx.doi.org/10.1186/s12931-019-1130-y

Ejemplares similares